NCT00553332 2016-04-22Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By SurgeryNational Cancer Institute (NCI)Phase 2 Completed29 enrolled 11 charts
NCT00604721 2014-05-28Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver CancerNational Cancer Institute (NCI)Phase 2 Completed19 enrolled 8 charts